乳腺MRI预测临床腋窝淋巴结阴性乳腺癌患者的淋巴血管侵犯
回顾性纳入140例术前临床腋窝淋巴结阴性、接受乳腺MRI及手术但省略腋窝淋巴结清扫的浸润性乳腺癌患者,评估临床特征与MRI表现。单因素分析显示肿瘤ADC值、瘤周ADC值及瘤周-肿瘤ADC比值与淋巴血管侵犯相关,多因素分析显示浸润成分病理大小和肿瘤ADC值为显著预测因子。肿瘤ADC值的观察者间一致性为中等程度。
要点
- 肿瘤ADC值是淋巴血管侵犯最显著的预测因子(OR 16.0,95%CI 1.89-136,p=0.01)。
- 年龄≤55岁患者中,肿瘤ADC值、瘤周ADC值及瘤周-肿瘤ADC比值均与淋巴血管侵犯显著相关。
- 肿瘤ADC值的观察者间一致性为中等程度(ICC=0.77,95%CI 0.70-0.83)。
核心结论
- 肿瘤ADC值、瘤周ADC值及瘤周-肿瘤ADC比值是年龄≤55岁患者淋巴血管侵犯的预测性MRI表现,其中肿瘤ADC值是最显著的预测因子,且两名解读经验不同的盲法观察者间一致性为中等程度。
研究设计与样本
- 回顾性研究,纳入140例患者的140个病灶,均为术前临床腋窝淋巴结阴性、接受术前乳腺MRI及乳腺手术并省略腋窝淋巴结清扫的浸润性乳腺癌患者;评估临床特征与MRI表现,包括T2信号强度比值、肿瘤ADC值、瘤周ADC值、瘤周-肿瘤ADC比值及对侧乳腺实质ADC值;行统计学分析筛选淋巴血管侵犯的显著预测因素并计算观察者间变异。
诊断标准与关键数值
- 单因素分析:肿瘤ADC值与淋巴血管侵犯相关(所有年龄p=0.005;年龄≤55岁p<0.001)。
- 单因素分析:瘤周ADC值与淋巴血管侵犯相关(年龄≤55岁p=0.04)。
- 单因素分析:瘤周-肿瘤ADC比值与淋巴血管侵犯相关(所有年龄p<0.001;年龄≤55岁p<0.001)。
- 多因素逻辑回归:浸润成分病理大小预测淋巴血管侵犯的OR为3.43(95%CI 1.41-8.32,p=0.007)。
- 多因素逻辑回归:肿瘤ADC值预测淋巴血管侵犯的OR为16.0(95%CI 1.89-136,p=0.01)。
临床应用与阅片要点
- 在年龄≤55岁、术前临床腋窝淋巴结阴性的浸润性乳腺癌患者中,可关注肿瘤ADC值、瘤周ADC值及瘤周-肿瘤ADC比值以辅助预测淋巴血管侵犯。
- 肿瘤ADC值的观察者间一致性为中等程度(ICC=0.77,95%CI 0.70-0.83),瘤周ADC值(ICC=0.53,95%CI 0.40-0.64)及瘤周-肿瘤ADC比值(ICC=0.49,95%CI 0.35-0.61)为中等程度一致性,T2信号强度比值为一般程度一致性(ICC=0.30,95%CI 0.15-0.45)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To retrospectively assess magnetic resonance imaging (MRI) findings that can predict lymphovascular invasion (LVI) in invasive breast cancer patients who were diagnosed with clinically negative axillary lymph nodes (LNs) preoperatively.
METHODS: This study included 140 lesions of 140 patients who underwent preoperative breast MRI and breast surgery, with omission of axillary LN dissection. Clinical characteristics and MRI findings were evaluated. The T2 signal intensity (SI) ratio (mean T2 SI of the tumor/mean T2 SI of the muscle), tumor apparent diffusion coefficient (ADC) value, peritumoral ADC value, peritumor-tumor ADC ratio (peritumoral maximum ADC value/tumor mean ADC value), and ADC value of the contralateral breast parenchyma were retrospectively assessed. Statistical analyses were performed to identify significant factors for predicting LVI. Inter-observer variability was calculated.
RESULTS: The tumor ADC value (all ages: p = 0.005; age ≤ 55: p < 0.001), peritumoral ADC value (age ≤ 55: p = 0.04), and peritumor-tumor ADC ratio (all ages: p < 0.001; age ≤ 55: p < 0.001) were significantly associated with LVI on univariate analysis. Multivariate logistic regression analysis revealed significant differences in the pathological size of the invasive component and the tumor ADC value for predicting LVI (odds ratio [OR]: 3.43; 95% confidence interval [CI]: 1.41-8.32; p = 0.007; OR: 16.0; 95% CI: 1.89-136; p = 0.01, respectively). Inter-observer agreement was substantial for the tumor ADC value (intraclass correlation coefficient [ICC] = 0.77; 95% CI: 0.70-0.83) and the ADC value of the contralateral breast parenchyma (ICC = 0.68; 95% CI: 0.59-0.76). There was moderate agreement for the peritumoral ADC value (ICC = 0.53; 95% CI: 0.40-0.64) and the peritumor-tumor ADC ratio (ICC = 0.49; 95% CI: 0.35-0.61) and fair agreement for the T2 SI ratio (ICC = 0.30; 95% CI: 0.15-0.45).
CONCLUSION: We found that the tumor ADC value, peritumoral ADC value, and peritumor-tumor ADC ratio were predictive MRI findings for LVI in patients aged ≤55. The tumor ADC value was the most significant predictor for LVI; moreover, inter-observer agreement for the tumor ADC value was substantial between two blinded observers with differences in interpretation experience.
引用
- Igarashi T, Furube H, Ashida H, et al. Breast MRI for prediction of lymphovascular invasion in breast cancer patients with clinically negative axillary lymph nodes. Eur J Radiol. 2018. PMID: 30292254. doi:10.1016/j.ejrad.2018.08.024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。